Milind Javle

Milind Javle is a Professor at The University of Texas MD Anderson Cancer Center, specializing in gastrointestinal oncology with a focus on biliary tract cancers and hepatobiliary malignancies. His research integrates genomic profiling, molecular pharmacology, and therapeutic innovation, emphasizing actionable genomic alterations in cholangiocarcinoma, including ERBB3 driver mutations and comparative genomic landscapes of pancreatic acinar cell carcinoma. Recent work explores the obesity paradox in immunotherapy outcomes, neoadjuvant immunotherapy for liver transplant recipients, and molecular resistance mechanisms to novel agents like tinengotinib. He also investigates Yttrium-90 radioembolization for durable local control, bridging radiation oncology and surgical oncology. His contributions advance precision oncology in underserved populations, exemplified by genomic studies of biliary tract cancer in the Indian population.